Lamberts S W, Bons E, Zuiderwijk J
Life Sci. 1986 Jul 14;39(2):97-102. doi: 10.1016/0024-3205(86)90442-x.
ACTH-release by primary cultures of rat anterior pituitary cells in response to CRF, vasopressin, epinephrine, norepinephrine and VIP is readily suppressible by dexamethasone. Rat hypothalamic extract-induced ACTH release is less sensitive to the inhibitory effect of dexamethasone than that elicited by CRF and the other secretagogues mentioned above. In studying the additive and potentiating effect on ACTH release of CRF in combination with vasopressin, VIP and the catecholamines it became evident that only the combination of micromolar concentrations of epinephrine or norepinephrine together with nanomolar concentrations of CRF will make ACTH release significantly less sensitive to the suppressive effect of dexamethasone. Other combinations of CRF and vasopressin or CRF and VIP will render ACTH release as suppressible to dexamethasone, as that elicited by each of these compounds by itself. This observation in the rat might explain at least in part the observation that a diminished suppressibility of the pituitary-adrenal axis to dexamethasone can be found in patients with psychiatric disease, especially depression.
大鼠垂体前叶细胞原代培养物对促肾上腺皮质激素释放因子(CRF)、血管加压素、肾上腺素、去甲肾上腺素和血管活性肠肽(VIP)的促肾上腺皮质激素(ACTH)释放反应很容易被地塞米松抑制。大鼠下丘脑提取物诱导的ACTH释放对地塞米松抑制作用的敏感性低于CRF和上述其他促分泌素所引发的ACTH释放。在研究CRF与血管加压素、VIP和儿茶酚胺联合使用对ACTH释放的相加和增强作用时发现,只有微摩尔浓度的肾上腺素或去甲肾上腺素与纳摩尔浓度的CRF联合使用,才会使ACTH释放对地塞米松抑制作用的敏感性显著降低。CRF与血管加压素或CRF与VIP的其他组合,会使ACTH释放对地塞米松的抑制作用与这些化合物单独作用时一样敏感。在大鼠身上的这一观察结果至少可以部分解释在精神疾病患者,尤其是抑郁症患者中发现的垂体 - 肾上腺轴对地塞米松抑制作用减弱的现象。